Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
Details for Australian Patent Application No. 2003282115 (hide)
International Classifications
Event Publications
25 March 2004 Complete Application Filed
Priority application(s): PCT/EP02/11328 08.10.02 EP; PCT/EP02/14836 23.12.02 EP
3 June 2004 Application Open to Public Inspection
Published as AU-B-2003282115
1 October 2009 Application Accepted
Published as AU-B-2003282115
28 January 2010 Standard Patent Sealed
3 November 2011 Assignment Registered
Janssen Pharmaceutica N.V. The patent has been assigned to Elanco Animal Health Ireland Limited
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003282116-RIGID PLASTIC PROTECTIVE CASE FOR A BLISTER PACK
2003282114-PREPOLYMER, POLYOL COMPOSITION AND PROCESS FOR MAKING A FLEXIBLE FOAM
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser